LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.43 | 84.90 | 3522 | 3459 | 1.0180 | 1.0067 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.43 | 84.90 | 244 | 3459 | 0.0705 | 0.2182 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.43 | 84.90 | 3548 | 3459 | 1.0255 | 1.0095 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 40.14 | 84.90 | 3662 | 3682 | 0.9946 | 0.9980 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 40.14 | 84.90 | 3736 | 3682 | 1.0146 | 1.0054 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 40.14 | 84.90 | 299 | 3682 | 0.0812 | 0.2605 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 40.14 | 84.90 | 3815 | 3682 | 1.0361 | 1.0131 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 41.84 | 84.90 | 3913 | 4003 | 0.9775 | 0.9918 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 41.84 | 84.90 | 3986 | 4003 | 0.9957 | 0.9985 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 41.84 | 84.90 | 316 | 4003 | 0.0789 | 0.2667 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 41.84 | 84.90 | 4080 | 4003 | 1.0192 | 1.0069 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 43.55 | 84.90 | 4111 | 4287 | 0.9587 | 0.9852 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 43.55 | 84.90 | 4241 | 4287 | 0.9891 | 0.9961 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 43.55 | 84.90 | 365 | 4287 | 0.0851 | 0.2940 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 43.55 | 84.90 | 4319 | 4287 | 1.0072 | 1.0026 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 45.25 | 84.90 | 4474 | 4539 | 0.9855 | 0.9949 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 45.25 | 84.90 | 4553 | 4539 | 1.0029 | 1.0010 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 45.25 | 84.90 | 379 | 4539 | 0.0835 | 0.2977 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 45.25 | 84.90 | 4628 | 4539 | 1.0194 | 1.0067 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.95 | 84.90 | 4800 | 4952 | 0.9692 | 0.9894 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.95 | 84.90 | 4894 | 4952 | 0.9882 | 0.9960 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.95 | 84.90 | 449 | 4952 | 0.0907 | 0.3283 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 46.95 | 84.90 | 5146 | 4952 | 1.0391 | 1.0131 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.65 | 84.90 | 5235 | 5328 | 0.9824 | 0.9941 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 48.65 | 84.90 | 5317 | 5328 | 0.9978 | 0.9993 | MN20160318_Q02 | H11 |